Specialized Depression Care & Innovative Modalities

You Don’t Have to Face Depression Alone. Hope and Healing Start Here.

Major Depressive Disorder (MDD) is treatable, and other options exist when first treatments haven’t helped enough. Learn about approaches such as TMS and Spravato® (esketamine), and find clinics that list them in MDDCare’s directory.

  • 5,600+ Listed Providers
  • FDA-Cleared & Approved Options
  • Insurance Information by Clinic
Advanced Clinical Pathways

Evidence-Based Advanced Interventions

When first-line antidepressants have not brought enough relief, other options such as TMS and esketamine may be considered with a qualified healthcare professional.

FDA-Cleared • Non-Systemic Outpatient • Zero Downtime
TMS therapy session in a calm clinical setting Neuromodulation Protocol

Transcranial Magnetic Stimulation (TMS)

TMS uses focused magnetic pulses, similar in strength to those used in MRI, to stimulate an area of the brain involved in mood regulation. Because it is non-invasive and does not circulate through the bloodstream, it avoids the systemic side effects associated with many medications. Common side effects include scalp discomfort and headache.

  • Targeted magnetic stimulation of the prefrontal cortex.
  • No anesthesia or sedation; most people can drive themselves after a session.
  • Studied in adults with MDD who did not improve enough with antidepressants; response varies.
Explore TMS Therapy & Clinics
SPRAVATO® REMS Required NMDA Receptor Antagonist
Spravato esketamine care in a supervised clinical suite Supervised Nasal Spray

Spravato® (Esketamine Nasal Spray)

SPRAVATO® is a prescription esketamine nasal spray for adults with treatment-resistant depression. Unlike traditional antidepressants that mainly act on monoamines, esketamine affects glutamate signaling. It is self-administered under direct supervision in a healthcare setting, followed by at least two hours of monitoring.

  • Some studies measured symptom changes within the first day; response varies.
  • Administered under direct healthcare-provider supervision through the SPRAVATO® REMS.
  • Coverage varies by plan; confirm with your insurer and the clinic.
Explore Esketamine Therapy & Clinics
Clinical Clarity

Understanding the Depression Spectrum

Depression is not one uniform condition. Understanding the differences can help you have more informed conversations with a healthcare professional.

Foundational Diagnosis

Major Depressive Disorder (MDD)

Characterized by a persistent low mood, pervasive loss of interest, sleep disruption, and profound fatigue persisting beyond two weeks. Significantly impairs cognitive clarity, professional life, and interpersonal relationships.

Standard First-Line Protocol:

SSRIs/SNRIs, targeted Cognitive Behavioral Therapy (CBT), and lifestyle stabilization.

Longitudinal Pattern

Recurrent & Persistent Depressive States

Episodes that cycle over multiple years (dysthymia or double depression). Often associated with functional exhaustion, chronic inflammation, or neuroplastic wear requiring maintenance regimens and enduring therapeutic alliance.

Options That May Be Considered:

Maintenance treatment plans, psychotherapy, and ongoing medication management.

Not sure which clinical category applies to your symptoms?

Take the free PHQ-9 depression self-check to organize your symptoms before talking with a healthcare professional.

Start Free Self-Check
Clinical Library

Explore our curated selection of articles on Depression care

Educational guides on depression, treatment options, and daily life.

Browse All Articles

How to beat Depression with TMS or Esketamine

Struggling with depression and looking for better treatment options? If traditional antidepressants haven’t worked, advanced therapies like TMS and Spravato (Esketamine) could…Read article

Is Your Teen Depressed? Recognizing the Early Signs of MDD

Teenagers go through mood swings, but when does sadness turn into something more serious? Major Depressive Disorder (MDD) in teens can be…Read article

How depression affects motivation & what you can do about it

Ever feel like even the smallest tasks feel overwhelming? You’re not alone. Depression doesn’t just affect mood—it also impacts motivation, energy, and…Read article

Depression Isn’t Just Mental: How MDD Impacts Your Body

Depression isn’t just in your head—it affects your whole body. While Major Depressive Disorder (MDD) is known for its emotional toll, it…Read article

Cutting-Edge Treatments for MDD: What’s Changing in Depression Care

Depression treatment is advancing beyond traditional medications. If you’ve struggled with antidepressants or are looking for more effective options, you’ll be glad…Read article

Sad or Depressed? How to Tell the Difference

Everyone feels sad sometimes, but when does it become something more serious? Sadness is a normal human emotion, while depression is a…Read article

Can Poor Sleep Cause Depression and Anxiety? Here’s the Connection

Tossing and turning at night? It’s not just frustrating—it could be affecting your mental health. Studies show that poor sleep can lead…Read article
Evidence & Clarity

Frequently Asked Questions

Educational answers about depression and treatment options. Discuss your situation with a qualified healthcare professional.

What is Major Depressive Disorder (MDD), and what causes it?

Major Depressive Disorder is a complex biological and psychological mood disorder, not a personal failing or temporary sorrow. It arises from an interplay of neurocircuitry dysregulation, genetic predispositions, chronic hormonal and inflammatory stressors, and altered neuroplasticity in mood-regulating areas such as the hippocampus and prefrontal cortex.

Does insurance cover TMS and Spravato® treatments?

Many insurance plans, including Medicare, may cover TMS and Spravato® for treatment-resistant depression when plan criteria are met, often with prior authorization. Coverage varies by plan, clinical indication, and treatment setting. Confirm benefits and requirements directly with your insurer and the clinic. MDDCare does not determine coverage.

How does Spravato® (esketamine) work?

Traditional antidepressants mainly act on monoamines such as serotonin and can take several weeks to reach full effect. Esketamine is an NMDA receptor antagonist that affects glutamate signaling. Some clinical studies measured symptom changes within the first day, but the exact mechanism is not fully understood and response varies.

How long do treatment courses typically last?

An acute TMS course typically involves sessions five days a week for about 6 weeks, sometimes followed by a taper; session length depends on the device and protocol. For treatment-resistant depression, Spravato® is given twice weekly in weeks 1–4, once weekly in weeks 5–8, then once weekly or every two weeks based on response.

How does TMS differ from standard medication?

Antidepressants circulate through the body via the bloodstream, which can cause side effects such as nausea, weight gain, fatigue, or sexual dysfunction. TMS delivers focused magnetic pulses to a specific brain region and does not circulate through the body. It can cause scalp discomfort or headache, and seizures are a rare risk.

Can MDD be prevented or permanently cured?

Clinicians generally avoid the word “cure,” but many people with MDD reach remission and stay well with ongoing care. Treatment plans may combine medication, psychotherapy, and options such as TMS or Spravato®, along with relapse-prevention strategies discussed with a healthcare professional.

For Psychiatric Clinics & Specialists

Expand Your Clinic’s Reach Across the Care Network

Are you a psychiatric clinic, TMS center, or mental health provider? List your clinic on MDDCare so people searching for depression care in your region can find your services, locations, and insurance information.

Ready to Transform Your Access Process?

InterventionFlow is the complete platform that streamlines TMS & Spravato access management.

Get Started